Linguist Haruhiko Kindaichi dies at 91

Linguist Haruhiko Kindaichi dies at 91

TOKYO, Japan - Japanese linguist Haruhiko Kindaichi (in file photo taken in April 2003) died of a stroke May 19 at a hospital in the city of Kofu, Yamanashi Prefecture, his family said. He was 91. Kindaichi, son of well-known linguist Kyosuke Kindaichi, graduated from the University of Tokyo and was professor at the Tokyo University of Foreign Studies and Sophia University. He was known for his research into dialects and accents. (Kyodo)

  • Product Code
  • ILEA000024898
  • Registered date
  • 2004/5/19 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • Media size
  • 565 × 755 pixel
  • Resolution
  • 72 dpi
  • Deployment size
  • 198.48(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Part of wreckage of sunken Japan GSDF chopper recovered

    Part of wreckage of sunken Japan GSDF chopper recovered

    Photo taken from a Kyodo News helicopter on May 2, 2023, shows a salvage vessel hauling a major part of the wreckage of a Japan Ground Self-Defense Force helicopter from the seabed off Miyako Island in the southern Japan prefecture of Okinawa. The GSDF helicopter went missing with 10 personnel on board on April 6.
      Tokyo Gas LNG tanks

      Tokyo Gas LNG tanks

      File photo taken from a Kyodo News helicopter on Nov. 12, 2021, shows liquefied natural gas tanks of Tokyo Gas Co. in Sodegaura in Chiba Prefecture, eastern Japan.
        Tokyo Gas LNG tanks

        Tokyo Gas LNG tanks

        File photo taken from a Kyodo News helicopter on Nov. 12, 2021, shows liquefied natural gas tanks of Tokyo Gas Co. in Sodegaura in Chiba Prefecture, eastern Japan.
          KM Biologics begins development of vaccine for novel coronavirus

          KM Biologics begins development of vaccine for novel coronavirus

          KM Biologics (Kita Ward, Kumamoto City) has started to develop a vaccine for a new coronavirus infection. At a press conference held on April 25, President Nagasato said, "Our strength lies in the fact that we have skilled technicians and facilities from our days at the Research Institute for Chemotherapy and Serotherapy (KAKETSUKEN). As a member of the Meiji Group, we will do our utmost to expand this business. The new drug will be developed jointly with the National Institute of Infectious Diseases, the Institute of Medical Science of the University of Tokyo, and the National Institute of Biomedical Innovation, Health and Nutrition. The company will consider using its Kikuchi Research Center in Kikuchi City, Kumamoto Prefecture, and its Koshi Plant in Koshi City, Kumamoto Prefecture, which are capable of producing vaccines for 57 million new influenza cases. (Photo taken on May 25, 2020, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images)
            Copper fiber sheet commercialized by Good Eye

            Copper fiber sheet commercialized by Good Eye

            Good Eye (Kiryu City, Gunma Prefecture) will release GUD Sheet, a copper fiber sheet with antibacterial and antiviral effects, in June. The company commercialized four types of masks, including one priced at 4,980 yen (excluding consumption tax). The GUD sheet is a polymer fiber covered with copper foil and coated with a visible light responsive photocatalyst. In an experiment on bacteriophage, a virus that infects bacteria, it was confirmed that rubbing a finger covered with the virus on the sheet for 30 seconds reduced the number of the virus to less than 1/1000.Professor Hideyuki Itabashi of the Graduate School of Science and Engineering, Gunma University, who also serves as the company's chairman, said, "We hope to start experiments in July. The photo shows copper fiber sheets commercialized as masks and chiefs. (Photo taken on May 19, 2020, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images)
              Aerology Labs' hybrid drone prototype, the AeroRange Pro.

              Aerology Labs' hybrid drone prototype, the AeroRange Pro.

              Aerology Lab (Minoh City, Osaka Prefecture) announced on April 14 that it has developed a prototype of a "purely Japanese" flying robot (drone), "AeroRange Pro" (photo), which consists entirely of parts made in Japan. In general, drones rely on parts made in China for most of their components. The company aims to start mass production in small lots by December. (Minato Ward, Osaka City), which operates an open innovation base, Kobashi Robotics (Minami Ward, Okayama City), which supports mass production, and Liberace (Shinjuku Ward, Tokyo), which comprehensively supports venture businesses from trial manufacture to mass production. The company is promoting speedy manufacturing in cooperation with town factories in Kansai and other regions. The hybrid drone combines an engine and an electric motor. It is said to be the industry's first purely domestic product in this field. Photo taken on May 14, 2020, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images
                Test plant that started operation at Subaru

                Test plant that started operation at Subaru

                SUBARU (Shikokuchuo City, Ehime Prefecture) will make a full-scale entry into the business of paramylon nanofiber (PNF), which is made from paramylon, a unique ingredient of fruit fly. The company plans to build a production system aiming at an annual production of 1,000 tons in five to seven years. The company will use an indoor facility to stably cultivate a highly proliferative greenbug strain discovered by Professor Masahiro Hayashi of Miyazaki University, the University of Miyazaki. (Photo taken on May 14, 2020, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images)
                  Sample collection by drive-through system implemented by Osaka Prefecture

                  Sample collection by drive-through system implemented by Osaka Prefecture

                  The prefectural government will increase the number of specimens collected and testing capacity, and increase the number of specimens that can be processed per day from 420 to 890. The number of specimen collection sites in the prefecture is expected to increase from the current 15 to more than 20. A prefectural government official said, "If we can increase the number of collection sites, we can reduce the number of days we have to wait for tests. In Japan, Nara Prefecture, Tokyo and other prefectures have introduced this method of collecting specimens. Photo: April 23, 2020, Osaka Prefecture, Credit: Nikkan Kogyo Shimbun / Kyodo News Images
                    A low-cost face shield invented by Osaka University and Charman

                    A low-cost face shield invented by Osaka University and Charman

                    The shape of the frame is based on a widely used design, with clips on both ends. We designed several types of frames, including a small size for women and children, and a structure that can be attached to a stationery clip when the accuracy of the 3D printer cannot be secured. The shield part by the file can be cut with scissors if you are concerned about fogging or collision with the surrounding area. Transparent book covers can also be used and are disposable. There is a worldwide shortage of protective gear, and in New York City, the U.S., it was reported that treatment activities were carried out wearing garbage bags. Professor Nakajima said, ???It???s best if we can use genuine products, but we need to think about using familiar items as substitutes when there???s a shortage.? The photo shows Professor Nakajima demonstrating the use of a face shield with a file. (Photo taken on April 3, 2020, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images)
                      Professor Inoue of University of Tokyo, announce the identification of a new coronavirus drug candidate

                      Professor Inoue of University of Tokyo, announce the identification of a new coronavirus drug candidate

                      Professor Junichiro Inoue and his colleagues at the University of Tokyo's Institute of Medical Science held a press conference on April 18 and announced that they had identified nafamostat. Nafamostat has been used for more than 30 years in Japan, and early clinical trials are expected to be conducted. The clinical research is expected to start by the beginning of April in cooperation with the National Center for Global Health and Medicine and others. When the new corona infects humans, proteins on the surface of the virus and proteins on the surface of human cells bind to each other, causing the outer membrane of the virus to fuse with the membrane of human cells. As a result, ribonucleic acid (RNA), which is the genetic information of the new corona, enters the human cell, and the virus multiplies. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)